Skip to main content

Advertisement

Log in

PVT1 and ZFAS1 lncRNAs expressions and their biomarker value in gastric cancer tissue sampling among Iranian population

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Background

lncRNAs are modulatory factors with critical function in the tumorigenesis pathways, introducing them as promising therapeutic and diagnostic biomarkers for different cancers. This study is thus aimed to evaluate the differences in PVT1 and ZFAS1 gene expression in tumorous tissues as compared with adjacent healthy non-tumorous biopsies of gastric cancer cases.

Methods

One hundred two pairs of tumorous and adjacent non-tumorous biopsies of GC cases were sampled. RNA isolation and cDNA production were carried out. The qRT-PCR was performed to evaluate the expression of PVT1 and ZFAS1 genes. Moreover, the associations between PVT1 or ZFAS1 and clinicopathological characteristics as well as the biomarker roles of the lncRNAs were assessed.

Results

The PVT1 and ZFAS1 expressions showed a significant increase and decrease in GC samples as compared with non-cancerous tissues, respectively. PVT1 expression was significantly associated with and lymph-node involvement (p = 0.0007). Moreover, ZFAS1 expression demonstrated a significant association with lymph-node involvement (p = 0.0005), and tumor size >5 cm (p = 0.003). The findings of the ROC curve revealed that PVT1 and ZFAS1 may act as a possible biomarker with AUC of 0.71 and 0.79, specificity of 78.43% and 79.41%, and sensitivity of 55.88% and 64.71%.

Conclusions

Regarding upregulation of PVT1 and downregulation of ZFAS1 in human GC samples, these genes may respectively act as oncogenic and tumor-suppressive factors in GC cases. Furthermore, PVT1 and ZFAS1 can be considered as possible biomarkers for the detection and treatment of GC cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The data are available if requested by the Editor or reviewers.

References

  1. Rajabi A, Riahi A, Shirabadi-Arani H, Moaddab Y, Haghi M, Safaralizadeh R (2020) Overexpression of HOXA-AS2 LncRNA in patients with gastric cancer and its association with helicobacter pylori infection. J Gastrointest Cancer. https://doi.org/10.1007/s12029-020-00549-y(PMID: 33174119)

  2. Kalan Farmanfarma K, Mahdavifar N, Hassanipour S, Salehiniya H. Epidemiologic study of gastric cancer in iran: a systematic review. Clin Expt Gastroenterol 2020;13:511–42 b (PMID: 33177859)

  3. Dastmalchi N, Safaralizadeh R, Banan Khojasteh SM. The correlation between microRNAs and Helicobacter pylori in gastric cancer. Pathogens Dis 2019;77(4):ftz039 (PMID: 31351000)

  4. Dastmalchi N, Khojasteh SMB, Nargesi MM, Safaralizadeh R. The correlation between lncRNAs and Helicobacter pylori in gastric cancer. Pathogens Dis 2019;77(9):ftaa004 (PMID: 31981356)

  5. Zhang X, Wang W, Zhu W et al (2019) Mechanisms and functions of long non-coding rnas at multiple regulatory levels. Int J Mol Sci 20(22):5573 (PMID: 31717266)

    Article  CAS  Google Scholar 

  6. Behzadi S, Baradaran B, Hosseinpourfeizi MA, et al. BC032913 as a novel antisense non-coding RNA is downregulated in gastric cancer. J Gastrointest Cancer 2020 (PMID: 32914372)

  7. Feng LL, Shen FR, Zhou JH, Chen YG (2019) Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity. Gene 696:105–112 (PMID: 30738960)

    Article  CAS  Google Scholar 

  8. Colombo T, Farina L, Macino G, Paci P. PVT1: a rising star among oncogenic long noncoding RNAs. BioMed Res Int 2015;2015:304208 (PMID: 25883951)

  9. Onagoruwa OT, Pal G, Ochu C, Ogunwobi OO (2020) Oncogenic role of PVT1 and therapeutic implications. Front Oncol 10:17 (PMID: 32117705)

    Article  Google Scholar 

  10. Yuan CL, Li H, Zhu L, Liu Z, Zhou J, Shu Y (2016) Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer. Neoplasma 63:442–449 (PMID: 26925791)

    Article  CAS  Google Scholar 

  11. Askarian-Amiri ME, Crawford J, French JD et al (2011) SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA 17(5):878–891 (PMID: 21460236)

    Article  CAS  Google Scholar 

  12. Nie F, Yu X, Huang M et al (2017) Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression. Oncotarget 8(24):38227–38238 (PMID: 27246976)

    Article  Google Scholar 

  13. Herrero R, Heise K, Acevedo J, et al. Regional variations in Helicobacter pylori infection, gastric atrophy and gastric cancer risk: the ENIGMA study in Chile. PloS One 2020;15(9):e0237515 (PMID: 32898138)

  14. Baj J, Korona-Glowniak I, Forma A et al (2020) Mechanisms of the epithelial-mesenchymal transition and tumor microenvironment in helicobacter pylori-induced gastric cancer. Cells 9(4):1055 (PMID: 32340207)

    Article  CAS  Google Scholar 

  15. Riquelme I, Saavedra K, Espinoza JA et al (2015) Molecular classification of gastric cancer: towards a pathway-driven targeted therapy. Oncotarget 6(28):24750–24779 (PMID: 26267324)

    Article  Google Scholar 

  16. Park JY, Forman D, Waskito LA, Yamaoka Y, Crabtree JE (2018) Epidemiology of helicobacter pylori and CagA-positive infections and global variations in gastric cancer. Toxins 10(4):163 (PMID: 29671784)

    Article  CAS  Google Scholar 

  17. Tan H, Zhang S, Zhang J et al (2020) Long non-coding RNAs in gastric cancer: new emerging biological functions and therapeutic implications. Theranostics 10(19):8880–8902 (PMID: 32754285)

    Article  CAS  Google Scholar 

  18. Gyvyte U, Kupcinskas J, Juzenas S, et al. Identification of long intergenic non-coding RNAs (lincRNAs) deregulated in gastrointestinal stromal tumors (GISTs). PloS One 2018;13(12):e0209342 (PMID: 30557328)

  19. Ahmad I, Valverde A, Ahmad F, Naqvi AR (2020) Long noncoding RNA in myeloid and lymphoid cell differentiation, polarization and function. Cells 9(2):269 (PMID: 31979061)

    Article  CAS  Google Scholar 

  20. Statello L, Guo CJ, Chen LL, Huarte M (2021) Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 22(2):96–118 (PMID: 33353982)

    Article  CAS  Google Scholar 

  21. Dastmalchi N, Safaralizadeh R, Nargesi MM (2020) LncRNAs: potential novel prognostic and diagnostic biomarkers in colorectal cancer. Curr Med Chem 27(30):5067–5077 (PMID: 30827228)

    Article  CAS  Google Scholar 

  22. Fattahi S, Nikbakhsh N, Taheri H, Ghadami E, Ranaee M, Akhavan-Niaki H (2021) LINC02688 and PP7080 as novel biomarkers in early diagnosis of gastric cancer. Non-coding RNA research 6:86–91

    Article  CAS  Google Scholar 

  23. Mohammadzadeh A, Baradaran B, Dastmalchi N, Hashemzadeh S, Safaralizadeh R (2021) The Correlation between helicobacter pylori infection and Lnc-OC1 expression in gastric cancer tissues in an Iranian population. J Gastrointest Cancer 52(2):600–605 (PMID: 32529394)

    Article  CAS  Google Scholar 

  24. Behzadi S, Baradaran B, Hosseinpourfeizi MA, Dastmalchi N, Rajabi A, Asadi M, Safaralizadeh R (2021) BC032913 as a novel antisense non-coding RNA is downregulated in gastric cancer. J Gastrointest Cancer 52(3):928–931 (PMID: 32914372)

    Article  CAS  Google Scholar 

  25. Kangarlouei R, Irani S, Noormohammadi Z, Memari F, Mirfakhraie R (2019) ANRIL and ANRASSF1 long noncoding RNAs are upregulated in gastric cancer. J Cell Biochem 120(8):12544–12548 (PMID: 30834580)

    Article  CAS  Google Scholar 

  26. Chaleshi V, Asadzadeh Aghdaei H, Nourian M, Iravani S, Jalaeikhoo H, Rajaeinejad M, Khoshdel AR, Naghoosi H. Association of MALAT1 expression in gastric carcinoma and the significance of its clinicopathologic features in an Iranian patient. Gastroenterol Hepatol Bed Bench 2021 Spring ;14(2):108–114 (PMID: 33968337)

  27. Jin L, Cai Q, Wang S, Wang S, Wang J, Quan Z (2020) Long noncoding RNA PVT1 promoted gallbladder cancer proliferation by epigenetically suppressing miR-18b-5p via DNA methylation. Cell Death Dis 11(10):871 (PMID: 33067424)

    Article  CAS  Google Scholar 

  28. Qiu C, Li S, Sun D, Yang S (2020) lncRNA PVT1 accelerates progression of non-small cell lung cancer via targeting miRNA-526b/EZH2 regulatory loop. Oncol Lett 19(2):1267–1272 (PMID: 32002028)

    CAS  PubMed  Google Scholar 

  29. Wang H, Huang Y, Yang Y (2020) LncRNA PVT1 regulates TRPS1 expression in breast cancer by sponging miR-543. Cancer Manag Res 12:7993–8004 (PMID: 32982402)

    Article  CAS  Google Scholar 

  30. Yan M, Pan XF, Liu Y, Zhao S, Gong WQ, Liu W (2020) Long noncoding RNA PVT1 promotes metastasis via miR-484 sponging in osteosarcoma cells. Eur Rev Med Pharmacol Sci 24(5):2229–2238 (PMID: 32196583)

    CAS  PubMed  Google Scholar 

  31. Tian Z, Cao S, Li C et al (2019) LncRNA PVT1 regulates growth, migration, and invasion of bladder cancer by miR-31/ CDK1. J Cell Physiol 234(4):4799–4811 (PMID: 30317572)

    Article  CAS  Google Scholar 

  32. Chen M, Zhang R, Lu L et al (2020) LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA. Aging 12(21):22291–22312 (PMID: 33188158)

    Article  Google Scholar 

  33. Kong R, Zhang EB, Yin DD et al (2015) Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16. Mol Cancer 14:82 (PMID: 25890171)

    Article  Google Scholar 

  34. Martinez-Barriocanal A, Arango D, Dopeso H (2020) PVT1 long non-coding RNA in gastrointestinal cancer. Front Oncol 10:38 (PMID: 32083000)

    Article  Google Scholar 

  35. Fan S, Fan C, Liu N, Huang K, Fang X, Wang K (2018) Downregulation of the long non-coding RNA ZFAS1 is associated with cell proliferation, migration and invasion in breast cancer. Mol Med Rep 17(5):6405–6412 (PMID: 29532866)

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Tian FM, Meng FQ, Wang XB (2016) Overexpression of long-noncoding RNA ZFAS1 decreases survival in human NSCLC patients. Eur Rev Med Pharmacol Sci 20(24):5126–5131 (PMID: 28051258)

    PubMed  Google Scholar 

  37. Sharma U, Barwal TS, Khandelwal A et al (2021) LncRNA ZFAS1 inhibits triple-negative breast cancer by targeting STAT3. Biochimie 182:99–107 (PMID: 33429003)

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was a part of the project entitled “The assessment of non-coding RNAs function in human malignancies” (Grant Number: 3522) performed at the University of Tabriz. The authors appreciate the participation of patients in this study.

Funding

This project has been financially supported by the University of Tabriz (Grant Code: 3522).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Reza Safaralizadeh.

Ethics declarations

Conflict of interest

None.

Ethical approval

The research was approved by the ethical committee of the Medical University of Tabriz with the code of IR.TABRIZU.REC.1398.015.

Consent to participate

All participants signed an informed consent form.

Consent to publication

All participants signed informed consent.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dastmalchi, N., Tayefeh-Gholami, S., Rajabi, A. et al. PVT1 and ZFAS1 lncRNAs expressions and their biomarker value in gastric cancer tissue sampling among Iranian population. Mol Biol Rep 48, 7171–7177 (2021). https://doi.org/10.1007/s11033-021-06709-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-021-06709-y

Keywords

Navigation